Crocs, Inc. logo

Crocs, Inc. (CROX)

Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS)
$
123. 14
-1.63
-1.3064%
$
5.98B Market Cap
- P/E Ratio
- Div Yield
1.02M Volume
0 Eps
$ 124.77
Previous Close
Add Transaction
Day Range
122.68 127.28
Year Range
73.21 141.28
Want to track CROX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Can Crocs (CROX) Stock Move Higher Again as Markets Stabilize?

Can Crocs (CROX) Stock Move Higher Again as Markets Stabilize?

Recent market volatility interrupted what might have been a sharp rally in Crocs (CROX) stock after the leading footwear company posted strong Q2 results last Thursday.

Zacks | 2 years ago
Insider Alert: Crocs Director Buys $247K of CROX Stock

Insider Alert: Crocs Director Buys $247K of CROX Stock

Crocs (NASDAQ: CROX ) stock is moving higher following an insider buy. The buy came just one day after the foam clogs company reported its second-quarter earnings.

Investorplace | 2 years ago
Is Crocs (CROX) a Great Value Stock Right Now?

Is Crocs (CROX) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 2 years ago
These 2 Magnificent Growth Stocks Are Set to Soar This Summer and Beyond

These 2 Magnificent Growth Stocks Are Set to Soar This Summer and Beyond

Regardless of market fluctuations, it's always a good time to invest in quality companies. Intuitive Surgical has a simple but effective business model that is driving impressive growth.

Fool | 2 years ago
Crocs Is an Incredible Buy After Earnings

Crocs Is an Incredible Buy After Earnings

Crocs is growing, and it's trading for a good value, especially if the Hey Dude brand picks up again.

Fool | 2 years ago
CROX Stock Is Falling Despite a Strong Q2. What's Causing the Footwear Fumbles?

CROX Stock Is Falling Despite a Strong Q2. What's Causing the Footwear Fumbles?

Crocs (NASDAQ: CROX ) stock is trading about 2% lower after the footwear company reported its second-quarter earnings. Crocs' revenue grew by 3.6% to $1.11 billion, beating the analyst estimate for $1.1 billion.

Investorplace | 2 years ago
Crocs (CROX) Q2 Earnings Beat, DTC Revenues Rise 8.9% Y/Y

Crocs (CROX) Q2 Earnings Beat, DTC Revenues Rise 8.9% Y/Y

Crocs' (CROX) second-quarter 2024 results benefit from its brand strength and higher revenues across regions.

Zacks | 2 years ago
Crocs Stock Loses Its Footing

Crocs Stock Loses Its Footing

Crocs (CROX) delivered record revenue and earnings with its second-quarter results, but an underwhelming profit projection put a damper on the footwear company's momentum.

Investopedia | 2 years ago
Crocs Stock Is Falling on Outlook Shock. Buyers Should Step Up.

Crocs Stock Is Falling on Outlook Shock. Buyers Should Step Up.

The casual-footwear maker's strong second-quarter earnings were overshadowed by a light third-quarter outlook. Investors shouldn't walk.

Barrons | 2 years ago
Crocs Earnings Hit a Record. Why the Stock Is Down.

Crocs Earnings Hit a Record. Why the Stock Is Down.

The casual-footwear firm walked all over second-quarter earnings and revenue estimates, and raised guidance. But there are still concerns over HeyDude.

Barrons | 2 years ago
Crocs shares sink on guidance miss despite ‘encouraging' Q2 report

Crocs shares sink on guidance miss despite ‘encouraging' Q2 report

Crocs, Inc. (NASDAQ:CROX) posted an earnings beat for the second quarter but shares of the footwear brand tumbled more than 7% on disappointing guidance. For 3Q, revenue is expected to be down 1.5% to up 0.5% from the year-ago quarter, with the Crocs brand seen growing 3% to 5% and HEYDUDE down 16% to 14%.

Proactiveinvestors | 2 years ago
Crocs (CROX) Tops Q2 Earnings and Revenue Estimates

Crocs (CROX) Tops Q2 Earnings and Revenue Estimates

Crocs (CROX) came out with quarterly earnings of $4.01 per share, beating the Zacks Consensus Estimate of $3.59 per share. This compares to earnings of $3.59 per share a year ago.

Zacks | 2 years ago
Loading...
Load More